Why Big Pharma Will Continue To Choose India For Clinical Research In 2025

Rare Disease Opportunity

 
• By Vibha Ravi
  
India Is Gaining Importance As A Clinical Trials Destination
R&D Activity In India Is Expected To Gain Pace (Shutterstock)

More from Pink Sheet Perspectives

More from Geography